Global Canine Arthritis Market Size, Share, Growth, Trends, and Forecast (2024 - 2031)
Global Canine Arthritis Market Scope: Historical Data (2021 – 2022), Base Year (2023), Forecast Period (2024 – 2031)
Market Segmentation: By Drug Class (Anti-Inflammatory, Nutraceutical Supplement, and Others), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
Market Overview
The Global Canine Arthritis Market was valued at USD 2,481.5 million in 2023 and is expected to reach USD 3,448.7 million by 2031 while growing at a CAGR of 4.2% during the forecast period (2024-2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Market Dynamics
This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global canine arthritis Market growth. Canine arthritis, or osteoarthritis, is a common condition in dogs, causing joint inflammation and degeneration. It involves cartilage breakdown in the joints, leading to pain, swelling, and reduced mobility. This condition, linked to aging or factors like genetics and injuries, can affect one or more joints in a dog's body.
Advancements in veterinary medicine and increasing awareness of canine health are expected to drive the growth of the Canine Arthritis market. However, challenges such as high treatment costs, strict regulations, and medication side effects may hinder market expansion.
Furthermore, the global canine arthritis industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.
Segmentation – By Drug Class Analysis
The Global Canine Arthritis Market is segmented among Anti-Inflammatory, Nutraceutical Supplements, and Others, based on Drug Class. In 2023, Anti-Inflammatory accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Global Canine Arthritis Market: Regional Analysis
Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Europe is expected to grow with the highest CAGR during the forecast period (2024 – 2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Competitive Landscape
Some of the key players operating in the market are Nutri-Vet, LLC, Boehringer Ingelheim, Liquid Health Inc., American Regent, Inc., Matsun Nutrition, Synflex America Inc., Thorne Research Inc., Vetalogica, and Elanco.
Table of Contents:
1. Research Methodology and Market Scope
Research Methodology
Market Scope
2. Executive Summary
3. Global Canine Arthritis Market Dynamics
Drivers
Restraints
Opportunity
4. Global Canine Arthritis Industry Analysis
PEST Analysis
Porter's Five Force Analysis
Recent Deals Analysis
5. Global Canine Arthritis Market Segmentation, By Drug Class
Global Canine Arthritis Market Share Analysis, By Drug Class
Global Canine Arthritis Market Growth Analysis, By Drug Class
Global Canine Arthritis Market Trends, By Drug Class
o Anti-Inflammatory
o Nutraceutical Supplement
o Others
6. Global Canine Arthritis Market Segmentation, By Region
Global Canine Arthritis Market Share Analysis, By Region
Global Canine Arthritis Market Growth Analysis, By Region
Global Canine Arthritis Market Trends, By Region
o North America
o Europe
o Asia Pacific
o Latin America
o Middle East
o Africa
7. Competitive Landscape
Nutri-Vet, LLC*
o Company Overview
o Financial Performance
o Key Development/Strategies
o SWOT Analysis
Boehringer Ingelheim
Liquid Health Inc.
American Regent, Inc.
Matsun Nutrition
Synflex America Inc.
Thorne Research Inc.
Vetalogica
Elanco
*Similar analysis will be provided for each company listed above.